eMC - trusted, up to date and comprehensive information about medicines
Link to eMC medicine guides website
eMC homepage
Get Medicines Compendium UK app here

Actavis UK Ltd

Whiddon Valley, Barnstaple, Devon, EX32 8NS, UK
Telephone: +44 (0)1271 311 200
Fax: +44 (0)1271 346 106
WWW: http://www.actavis.co.uk
Medical Information Direct Line: +44 (0)1271 311 257
Medical Information e-mail: medinfo@actavis.co.uk

Before you contact this company: often several companies will market medicines with the same active ingredient. Please check that this is the correct company before contacting them. Why?


Summary of Product Characteristics last updated on the eMC: 08/07/2008
SPC Yeast-Vite


Go to top of the page
1. NAME OF THE MEDICINAL PRODUCT

Yeast-Vite


Go to top of the page
2. QUALITATIVE AND QUANTITATIVE COMPOSITION

Caffeine EP 50.0 MG

Nicotinamide 1.75 MG

Thiamine Hydrochloride (Vitamin B1) 0.167 MG

Riboflavin (Vitamin B2) 0.167 MG


Go to top of the page
3. PHARMACEUTICAL FORM

Tablet


Go to top of the page
4. CLINICAL PARTICULARS

Go to top of the page
4.1 Therapeutic indications

1. For the relief of fatigue and drowsiness.

2. The maximum daily dose will supply the recommended daily amount of Vitamins B1, B2 and Nicotinamide.


Go to top of the page
4.2 Posology and method of administration

Adults and Children aged 12 years and over

2 tablets every 3 – 4 hours as required.

Do not exceed 12 tablets in any period of 24 hours.

Not to be given to children under 12 years of age, except on medical advice.

The Elderly

The normal adult dose should be taken.


Go to top of the page
4.3 Contraindications

Known sensitivity to caffeine. Hypersensitivity to any of the ingredients.


Go to top of the page
4.4 Special warnings and precautions for use

Label Warnings

Do not exceed the stated dose.

If symptoms persist, consult your doctor.

Keep out of reach of children.


Go to top of the page
4.5 Interaction with other medicinal products and other forms of interaction

Caffeine may enhance the action of Ergotamine. High doses may cause tremor and palpitations. Patients should avoid excessive intake of coffee or tea.

Other drugs which may have their action altered by caffeine are idrocilamide, mexiletine, ciprofloxacin, enoxacin, pipemidic acid, fluvoxamine, phenylpropanolamie, phenytoin, clozapine, lithium, theophylline, pentobarbital, diazepam and methoxsalen.


Go to top of the page
4.6 Pregnancy and lactation

Consult a doctor before using if you are pregnant or breast-feeding. Caffeine may cause irritability to the breast-fed baby, therefore nursing mothers should use with caution.


Go to top of the page
4.7 Effects on ability to drive and use machines

None known.


Go to top of the page
4.8 Undesirable effects

High doses of caffeine may cause tremor and palpitations.


Go to top of the page
4.9 Overdose

Any symptoms of over dosage would be related to the caffeine content. Mild over dosage leads to nausea, headache and insomnia; Major over dosage causes restlessness, excitement, muscle tremor, tinnitus, tachycardia and extrasystoles. Later there may be scintillating scotoma (blind or partially blind areas in the visual fields).

In mild to moderate over dosage, no particular treatment is indicated. In major over dosage the stomach should be emptied either by inducing emesis or by intubation and lavage. Stimulation of the nervous system may be controlled by administration, intravenously if necessary, of a tranquilliser.


Go to top of the page
5. PHARMACOLOGICAL PROPERTIES

Go to top of the page
5.1 Pharmacodynamic properties

Caffeine is a mild stimulant.

The maximum daily dose of product will supply the recommended daily amount of vitamins B1, B2 and nicotinamide.


Go to top of the page
5.2 Pharmacokinetic properties

Not applicable


Go to top of the page
5.3 Preclinical safety data

None stated.


Go to top of the page
6. PHARMACEUTICAL PARTICULARS

Go to top of the page
6.1 List of excipients

Dried Yeast (1973)

Powdered Clove

Colloidal Anhydrous Silica

Micro Crystalline Cellulose

Lactose

Dispersed Brown 16658 (E124, E104, E132)

Maize Starch

Magnesium Stearate


Go to top of the page
6.2 Incompatibilities

Iodine, silver salts, tanning, strong caustic alkali.


Go to top of the page
6.3 Shelf life

Three years


Go to top of the page
6.4 Special precautions for storage

Store at or below 25°C in a dry place.


Go to top of the page
6.5 Nature and contents of container

a) Polypropylene securitainer, with polythene closure and polyether wad, containing 50 or 100 tablets.

b) Cylindrical, white (HDPE) bottle with a laminate membrane neck seal. A polypropylene screw cap and polyether wad, containing 50 or 100 tablets.

c) Cylindrical, white (HDPE) bottle, with an orange child resistant tamper evident lined closure. The bottle is fitted with a polyether wad and contains 50 or 100 tablets.

d) Blister packs comprising 25µ hard temper aluminium foil with 250µ opaque PVC film containing 12, 24 or 48 tablets.


Go to top of the page
6.6 Special precautions for disposal and other handling

None stated.


Go to top of the page
7. MARKETING AUTHORISATION HOLDER

Actavis Group PTC ehf

Reykjavíkurvegi 76-78

220 Hafnarfjordur

Iceland.


Go to top of the page
8. MARKETING AUTHORISATION NUMBER(S)

PL 30306/0081


Go to top of the page
9. DATE OF FIRST AUTHORISATION/RENEWAL OF THE AUTHORISATION

19 June 2002


Go to top of the page
10. DATE OF REVISION OF THE TEXT

Go to top of the page
11 DOSIMETRY

Not Applicable


Go to top of the page
12 INSTRUCTIONS FOR PREPARATION OF RADIOPHARMACEUTICALS

Not Applicable



More information about this product

Link to this document from your website: http://www.medicines.org.uk/emc/medicine/20975/SPC/


Active Ingredients/Generics

 
   caffeine
   nicotinamide
   thiamine
   riboflavin